Sign In
Buy CNS
$80.79
-1.71 (-2.07%)
At Close: Jul 21, 2026
Cohen & Steers Quality Income Realty Fund, Inc. (RQI) Notification of Sources of Distribution Under Section 19(a)
04:00pm, Monday, 30'th Mar 2026
NEW YORK, March 30, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") with information regarding the sources of
Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
04:00pm, Monday, 30'th Mar 2026
NEW YORK, March 30, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the sou
JHG or CNS: Which Is the Better Value Stock Right Now?
12:40pm, Friday, 27'th Mar 2026
Investors looking for stocks in the Financial - Investment Management sector might want to consider either Janus Henderson Group plc (JHG) or Cohen & Steers Inc (CNS). But which of these two stocks is
DALLAS--(BUSINESS WIRE)--Lantern Pharma and Starlight Therapeutics Announce FDA Clearance of IND for a Planned Phase 1 Pediatric CNS Cancer Trial of STAR-001.
SACRAMENTO, Calif., March 26, 2026 /PRNewswire/ -- Lunai Bioworks, Inc. (NASDAQ: LNAI) today announced it has executed a binding $20 million strategic transaction to acquire blood-brain barrier (BBB)
Cohen & Steers Closed-End Funds Declare Distributions for April, May and June 2026
05:06pm, Tuesday, 24'th Mar 2026
NEW YORK, March 24, 2026 /PRNewswire/ -- The Board of Directors of the Cohen & Steers Closed-End Funds announced today the monthly distributions for April, May and June 2026, as summarized in the char
What Active REIT Managers Bought And Sold In Q4 2025
07:15am, Saturday, 21'st Mar 2026
Top REIT investors are quietly repositioning their portfolios, revealing where the “smart money” sees opportunity. Several clear sector themes are emerging from recent 13F filings. But the biggest
This New $7 Million Bet Targets a CNS Drug Maker With Phase 3 Trial Underway and 27% Stock Gain
11:37am, Wednesday, 18'th Mar 2026
Superstring Capital Management purchased 37,433 shares of Axsome Therapeutics in the fourth quarter. The quarter-end position value was $6.84 million, representing a new holding in Axsome Therapeutics
Alto Neuroscience Announces Participation at the Stifel 2026 Virtual CNS Forum
08:03am, Friday, 13'th Mar 2026
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)---- $anro #cns--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medici
Acadia Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum
04:05pm, Thursday, 12'th Mar 2026
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate in a fireside chat at the Stifel 2026 Virtual CNS Forum on Tuesday, March 17, 2026 at 8:
Korsana Biosciences to Present at the Stifel 2026 Virtual CNS Forum
08:00am, Thursday, 12'th Mar 2026
WALTHAM, Mass.--(BUSINESS WIRE)--Korsana Biosciences, Inc. (“Korsana” or the “Company”), a biotechnology company discovering and developing novel therapies to reduce the burden of neurodegener
LG CNS and Palantir Announce Strategic Partnership to Accelerate AI Transformation
07:00pm, Wednesday, 11'th Mar 2026
MIAMI & SEOUL, South Korea--(BUSINESS WIRE)--LG CNS Co., Ltd. and Palantir Technologies Inc. (NASDAQ: PLTR), a leading provider of AI operating systems, today announced a deepened strategic partnershi
JHG vs. CNS: Which Stock Is the Better Value Option?
12:42pm, Wednesday, 11'th Mar 2026
Investors with an interest in Financial - Investment Management stocks have likely encountered both Janus Henderson Group plc (JHG) and Cohen & Steers Inc (CNS). But which of these two stocks offers v
Cohen & Steers Announces Plan to Convert the Cohen & Steers Future of Energy Fund to ETF
09:12am, Wednesday, 11'th Mar 2026
NEW YORK, March 11, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today announced plans to convert the Cohen & Steers Future of Energy Fund, a U.S. mutual fund designed to capitalize on opport
CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline
08:35am, Wednesday, 11'th Mar 2026
Newly formed executive team initiates global search for differentiated therapeutic assets for neurology and oncology indications, two of biopharma's largest and fastest-growing markets Strategic trans
